The Use of an Anterior Chamber Maintainer as a Sole Fluid Source in Micro Incision Cataract Surgery as Compared to a Standard Phacoemulsification Procedure
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this study is to compare the use of an Anterior Chamber Maintainer (ACM) as the sole fluid source in phacoemulsification micro incision cataract surgery (using 1.1mm corneal incision) as opposed to conventional coaxial phacoemulsification (using 2.4mm corneal incision).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2012
CompletedStudy Start
First participant enrolled
March 1, 2012
CompletedFirst Posted
Study publicly available on registry
March 14, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedMarch 14, 2012
March 1, 2012
1 year
February 19, 2012
March 13, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Corneal temperature
Continuous corneal temperature will be measured during cataract surgery using an infra red thermal imaging system
up to 12 months
Secondary Outcomes (1)
Anterior chamber stability
up to 12 months
Study Arms (2)
Tri-MICS
EXPERIMENTALConventional Phaco
ACTIVE COMPARATORInterventions
A Tri-MICS system will be used with a sleeveless Kelman 20G tip through a 1.1mm CCI. A specialized 19G anterior chamber maintainer, with thin walls and a large internal diameter of 0.9mm will be inserted through a 1.1mm CCI.
a conventional Phaco with sleeved Kelman 20G tip, through a 2.4mm CCI
Eligibility Criteria
You may qualify if:
- Bilateral Cataract
- Ability to understand and sign on an inform consent form.
- whiling to undergo bilateral cataract surgery.
You may not qualify if:
- Mature Cataract
- PXF
- Uveitis
- Corneal Pathology
- Endothelial cell density\<1500 cells/mm
- Glaucoma
- Extreme Hyperopia / shallow anterior chamber
- Extreme Myopia
- s/p Ophthalmic Trauma / Surgery
- Allergy to Penicillin / IOD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Meir Medical Center
Kfar Saba, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
February 19, 2012
First Posted
March 14, 2012
Study Start
March 1, 2012
Primary Completion
March 1, 2013
Study Completion
March 1, 2013
Last Updated
March 14, 2012
Record last verified: 2012-03